GTS Securities’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-381,700
Closed -$1.08M 1781
2024
Q3
$1.08M Buy
381,700
+260,200
+214% +$596K ﹤0.01% 2098
2024
Q2
$149K Buy
121,500
+47,900
+65% +$43K ﹤0.01% 3531
2024
Q1
$58.4K Sell
73,600
-48,700
-40% -$44.3K ﹤0.01% 3611
2023
Q4
$116K Sell
122,300
-52,300
-30% -$51.4K ﹤0.01% 3718
2023
Q3
$189K Buy
+174,600
New +$208K ﹤0.01% 3437

Other funds holding CLOV

GTS Securities's CLOV Position: Q1 2026 in Review

GTS Securities sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 11,123 shares — an estimated $26.1K sold.

GTS Securities first reported a position in CLOV in Q1 2024 and held it in 3 quarters. The position peaked at $89.8K in Q2 2024. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • GTS Securities reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 11,123 Clover Health Investments shares in Q1 2026, an estimated $26.1K.
  • GTS Securities first reported a position in Clover Health Investments in Q1 2024 and held it in 3 quarters.
  • GTS Securities's Clover Health Investments position peaked at $89.8K in Q2 2024.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.